Merck MRK
NYSE MRK
$146.77 -0.36 (-0.24%)
At close: Sep 18, 2026 · 4:00 PM EDT

Merck (MRK) Goodwill & Intangibles (2009 - 2026)

Merck's (MRK) quarterly Goodwill & Intangibles came in at $46.6 billion in Q2 2026, up 26.58% year-over-year from $36.8 billion in Q2 2025, and down 1.62% quarter-over-quarter from $47.3 billion in Q1 2026.

Analysis

Merck (MRK) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Goodwill & Intangibles for 18 consecutive years, with $46.6 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles rose 26.58% year-over-year to $46.6 billion in Q2 2026; TTM through Jun 2026 was $46.6 billion, a 26.58% increase from a year earlier, with the FY2025 full-year figure at $48.3 billion, up 26.87% from the prior year.
  • Goodwill & Intangibles was $46.6 billion for Q2 2026 at Merck, down from $47.3 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $48.3 billion in Q4 2025 and troughed at $36.8 billion in Q2 2025.
  • A 5-year average of $41.1 billion and a median of $40.6 billion in 2023 frame the typical range for Goodwill & Intangibles.
  • Across the five-year window, Goodwill & Intangibles surged 34.51% in 2022 and retreated 7.26% in 2023, its largest moves.
  • Over 5 years, Goodwill & Intangibles stood at $41.5 billion in 2022, then dropped by 5.46% to $39.2 billion in 2023, then retreated by 2.98% to $38.0 billion in 2024, then increased by 26.87% to $48.3 billion in 2025, then retreated by 3.52% to $46.6 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $46.6 billion (Q2 2026), $47.3 billion (Q1 2026), and $48.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.56 Bn
Mar 31, 2026 47.33 Bn
Dec 31, 2025 48.26 Bn
Sep 30, 2025 36.90 Bn
Jun 30, 2025 36.78 Bn
Mar 31, 2025 37.44 Bn
Dec 31, 2024 38.04 Bn
Sep 30, 2024 38.71 Bn
Jun 30, 2024 38.15 Bn
Mar 31, 2024 38.75 Bn
Dec 31, 2023 39.21 Bn
Sep 30, 2023 40.38 Bn
Jun 30, 2023 40.86 Bn
Mar 31, 2023 41.07 Bn
Dec 31, 2022 41.47 Bn
Sep 30, 2022 42.53 Bn
Jun 30, 2022 43.71 Bn
Mar 31, 2022 44.28 Bn
Dec 31, 2021 44.20 Bn
Sep 30, 2021 32.25 Bn